Prothena Corp. plc buy Chardan Capital
Start price
21.02.25
/
50%
€16.20
Target price
21.02.26
€38.18
Performance (%)
-47.53%
Price
12:45
€8.50
Summary
This prediction is currently active. Massive losses of -47.53% have been the result for the BUY prediction by Chardan_Capital. This prediction currently runs until 21.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Prothena Corp. plc | -8.108% | -8.108% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Chardan_Capital for this prediction
In the thread Prothena Corp. plc diskutieren
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat